PROKIDNEY CORP. - Ordinary Shares (PROK)

CUSIP: G7S53R104

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Ordinary Shares
Shares outstanding
129,821,091
Total 13F shares
47,997,221
Share change
-2,958,704
Total reported value
$42,032,793
Put/Call ratio
192%
Price per share
$0.88
Number of holders
68
Value change
-$2,665,006
Number of buys
32
Number of sells
27

Quarterly Holders Quick Answers

What is CUSIP G7S53R104?
CUSIP G7S53R104 identifies PROK - PROKIDNEY CORP. - Ordinary Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROKIDNEY CORP. - Ordinary Shares (PROK) as of Q1 2025

As of 31 Mar 2025, PROKIDNEY CORP. - Ordinary Shares (PROK) was held by 68 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 47,997,221 shares. The largest 10 holders included SUVRETTA CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Bleichroeder LP, STATE STREET CORP, Brown University, NORTHERN TRUST CORP, and Hennion & Walsh Asset Management, Inc.. This page lists 68 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.